Le Lézard
Classified in: Transportation, Health, Covid-19 virus
Subjects: ASI, CSR

Boeing Donates 250,000 Medical Masks to Battle Coronavirus in China


CHICAGO, Jan. 29, 2020 /PRNewswire/ -- Boeing [NYSE: BA] today announced a donation of 250,000 medical-grade respiratory masks to address medical supply shortages in China. The masks will be provided to local health officials battling the spread of the coronavirus in Wuhan City, Hubei Province, and Zhoushan, Zhejiang Province.

"Our thoughts continue to be with all those in China dealing with the health impacts related to the coronavirus," said Boeing President and CEO Dave Calhoun. "Through our donation, it is our hope that we can help limit the spread of this virus and ease the burden on local aid workers and medical personnel."  

The health and well-being of Boeing employees and their families remains a top priority for the company. Boeing continues to monitor the situation closely and has advised employees to heed all local public health warnings. To date, the company has provided 25,000 medical-grade respiratory masks for employees working in the region.

About Boeing

Boeing is the world's largest aerospace company and leading provider of commercial airplanes, defense, space and security systems, and global services. A top U.S. exporter, the company supports commercial and government customers in more than 150 countries. Boeing employs more than 150,000 people worldwide and leverages the talents of a global supplier base. Building on a legacy of aerospace leadership, Boeing continues to lead in technology and innovation, deliver for its customers and invest in its people and future growth.

Contacts

Michelle Mei
Boeing China
Office: +86 (10) 59255507
[email protected]

Jason Capeheart
Boeing Communications
Office: +1 312 544 2568
[email protected]

SOURCE Boeing


These press releases may also interest you

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

17 mai 2024
Federal, provincial and territorial (FPT) ministers responsible for culture and heritage held their annual meeting in Whitehorse, Yukon, on May 15?17, 2024, to discuss priority topics, share information and exchange best practices on current issues...

17 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

17 mai 2024
The TCW Group, a leading global asset management firm, today announced that, effective May 30, 2024, the listing exchange for shares of each of the following series (each, an "ETF" and, collectively, the "ETFs") of TCW ETF Trust (the "Trust") will be...

17 mai 2024
BioLineRx Ltd. ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a notification letter from the Nasdaq Stock Market LLC...



News published on and distributed by: